CG Oncology (CGON) Other Non-Current Assets (2023 - 2026)
CG Oncology posted quarterly Other Non-Current Assets of $2.7 million for Q1 2026, up 418.6% year-on-year from $516000.0 in Q1 2025, and up 59.48% on a QoQ basis from $1.7 million in Q4 2025.
CG Oncology (CGON) has 4 years of Other Non-Current Assets data on file, last reported at $2.7 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 418.6% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 418.6% YoY), and the FY2025 full-year result was $1.7 million, up 1685.11% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.7 million, up from $1.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4.7 million in Q4 2023 and bottomed at $53000.0 in Q1 2024.
- The 4-year median for Other Non-Current Assets is $315000.0 (2025), against an average of $1.0 million.
- The widest annual swing landed in 2024, when Other Non-Current Assets slumped 97.99%; it then surged 1685.11% in 2025.
- A 4-year view of Other Non-Current Assets shows it stood at $4.7 million in 2023, then plunged by 97.99% to $94000.0 in 2024, then soared by 1685.11% to $1.7 million in 2025, then jumped by 59.48% to $2.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $2.7 million (Q1 2026), $1.7 million (Q4 2025), and $114000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | 2.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 522,000.00 |
| Mar 31, 2025 | 516,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 4.67 Mn |